Xeomin 100-U Vials

Xeomin® is unique. It was the first clinically proven anti-wrinkle injection uniquely purified to remove proteins unnecessary for treatment.Xeomin is indicated for temporary improvement in the appearance of moderate to s…

$511.00

Product Details

Xeomin® is unique. It was the first clinically proven anti-wrinkle injection uniquely purified to remove proteins unnecessary for treatment.

Xeomin is indicated for temporary improvement in the appearance of moderate to severe glabellar lines in adult patients. Xeomin can help differentiate your practice. Xeomin is different in ways that matter to you and to your patients.

Consistency without excess - that's the SmartToxin.

Made to keep working, treatment after treatment. Specifically designed to deliver only what your patients need for frown line treatment. That means beauty is on your terms, and that’s a beautiful thing.

FDA approved. Clinically proven.

Neurotoxins, such as Xeomin®, are prescription medications that block the release of chemicals that cause these muscle contractions so frown lines are softened.

Xeomin® is a Botulinum Toxin Type A that blocks transmission of acetylcholine (ACh) from neuron to muscle
This inhibits muscle contraction and causes muscle paresis (weakness) or paralysis
Botulinum Toxin Type A only affects “cholinergic neurons” (neurons which use acetylcholine as a neurotransmitter)
Botulinum Toxin Type A effects dissipate after ~ 3 months because new SNAP-25 proteins take 3 months to be synthesized1

Before and After Xeomin:

Baseline and 30 Day Images

Anna

“I first started getting anti-wrinkle injections from my provider two years ago. It’s honestly my favorite form of self-care. When I found out about an anti-wrinkle injection that’s double-purified without unnecessary proteins, I made the switch and never looked back. Bye frown lines!”

Aziza

“I am all about taking care of everyone else, which is why it feels so good to have done something just for me. Treating my frown lines the double-purified way has been a huge turning point for me. I look in the mirror and love what I see.”

Astrid

“As someone who works in skincare, self-care is so important to me. I meditate. I do yoga. But I had never had my frown lines treated. I got a double-purified injection that’s free of unnecessary proteins, and I am so glad I tried Xeomin first.”

Statement represents the experience and opinion of the individual shown here. Individual has been compensated. Xeomin is a temporary treatment. Individual results may vary.

Molecule:

Xeomin's Core Neurotoxin

Neurotoxin with Complexing / Unneccessary Proteins

Our precise manufacturing process

Xeomin is uniquely purified and precisely manufactured in a German facility using using our advanced XTRACT technology™ to isolate the therapeutic component.

The active ingredient of Xeomin is botulinum serotype A. Merz takes the toxin complex and employs a precise manufacturing process that isolates the therapeutic component and removes the complexing/unnecessary proteins to produce Xeomin. Complexing/unnecessary proteins accompany the active neurotoxin but do not play an active role in treatment. Studies have not been performed to determine whether the presence or absence of complexing/unnecessary proteins has a long-term effect on safety or efficacy.

Xpectations Delivered

With nearly 15 years of clinical and global experience, Xeomin® has a well-established efficacy and safety profile

In 2 randomized, double-blind, multicenter clinical trials, Xeomin was proven to temporarily improve the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.1-3 The most commonly observed adverse reaction incidence ≥2% of patients and greater than placebo) for Xeomin was headache (5.4%).

SIGNIFICANTLY SUPERIOR EFFICACY OVER PLACEBO

Composite treatment success: Study 1 – Xeomin 60%, Placebo 0%; Study 2 – Xeomin 48%, Placebo 0%

Up to 4 months of Xeomin efficacy and patient satisfaction in a majority of patients

In a prospective, multicenter, randomized, double-blind, parallel trial, Xeomin was randomized 1:1 vs another neurotoxin. The study enrolled 250 healthy female patients (≥18 years old) with glabellar lines of at least moderate severity at maximum frown. Xeomin demonstrated comparable efficacy and duration up to four months. Patients were classified as responders only if they had a ≥1 point improvement from the baseline on the Facial Wrinkle Scale (FWS) at maximum frown, as assessed by the independent review panel using subject photographs at one month post treatment.